Related Experiment Video
Updated: Sep 23, 2025

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities
Hong-Yan Zhu1, Di Zhang1, Qi Zhang2
1College of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 Jilin China zhaoyan@jlau.edu.cn gaoyugang_2006@163.com +86 431 84533358 +86 431 84533358.
A novel 4-hydroxybenzyl alcohol derivative, 2FHBA, demonstrates potent sedative-hypnotic activity. This compound may offer a new therapeutic approach for insomnia by interacting with key neurotransmitter systems.
Area of Science:
- Neuroscience
- Pharmacology
- Natural Product Chemistry
Background:
- 4-Hydroxybenzyl alcohol (HBA) from *Gastrodia elata* impacts the central nervous system.
- Developing HBA derivatives can lead to compounds with enhanced bioactivity.
- Understanding the neurochemical mechanisms of HBA is crucial for therapeutic applications.
Purpose of the Study:
- Synthesize novel HBA derivatives to identify compounds with superior sedative-hypnotic effects.
- Evaluate the efficacy of these derivatives in preclinical models of sleep and wakefulness.
- Elucidate the potential neurochemical pathways involved in the action of the most potent derivative.
Main Methods:
- Synthesis of ten 4-hydroxybenzyl alcohol derivatives from HBA and various carboxylic acids.
- Assessment of sedative effects using spontaneous locomotor activity tests in mice.
- Evaluation of hypnotic effects in conjunction with pentobarbital-induced sleep.
- Investigation of the ability of the lead compound to reverse chemically induced insomnia models.
- Analysis of synergistic effects with 5-hydroxytryptophan (5-HTP).
Main Results:
- 4-Hydroxybenzyl alcohol 3-furancarboxylic acid diester (2FHBA) displayed the most significant sedative-hypnotic activity.
- 2FHBA effectively reversed insomnia induced by p-chlorophenylalanine (pCPA), flumazenil (FLU), and thiosemicarbazide (TSC).
- A synergistic effect was observed between 2FHBA and 5-hydroxytryptophan (5-HTP).
Conclusions:
- 2FHBA exhibits strong potential as an anti-insomnia agent.
- The observed effects of 2FHBA suggest a mechanism involving the serotonergic and GABAergic systems.
- Further research into 2FHBA could lead to novel insomnia therapeutics.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...

